AI assistant
WESTLAKE CORP — Director's Dealing 2021
Feb 18, 2021
30551_dirs_2021-02-18_1caea810-0693-4d7c-ae75-8ff4c9485a41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2021-02-16
Reporting Person: Bender Mark Steven (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-16 | Common Stock | M | 3230 | — | Acquired | 32188 | Direct |
| 2021-02-18 | Common Stock | F | 808 | $85.082 | Disposed | 31380 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-16 | Restricted Stock Units | $ | M | 3230 | Disposed | Common Stock (3230) | Direct |
Footnotes
F1: Restricted stock units convert into Issuer's shares of common stock on a one-for-one basis.
F2: On February 16, 2018, the reporting person was granted 3,230 restricted stock units vesting on the third anniversary of the grant date.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $85.06 to $85.80, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.